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Craving is a core feature of tobacco use disorder as well as a significant predictor of 
smoking relapse. Studies have shown that appetitive smoking-related stimuli (e.g., some-
one smoking) trigger significant cravings in smokers impede their self-control capacities 
and promote drug seeking behavior. In this review, we begin by an overview of functional 
magnetic resonance imaging (fMRI) studies investigating the neural correlates of smok-
ers to appetitive smoking cues. The literature reveals a complex and vastly distributed 
neuronal network underlying smokers’ craving response that recruits regions involved 
in self-referential processing, planning/regulatory processes, emotional responding, 
attentional biases, and automatic conducts. We then selectively review important factors 
contributing to the heterogeneity of results that significantly limit the implications of these 
findings, namely between- (abstinence, smoking expectancies, and self-regulation) and 
within-studies factors (severity of smoking dependence, sex-differences, motivation to 
quit, and genetic factors). Remarkably, we found that little to no attention has been 
devoted to examine the influence of personality traits on the neural correlates of cigarette 
cravings in fMRI studies. Impulsivity has been linked with craving and relapse in sub-
stance and tobacco use, which prompted our research team to examine the influence 
of impulsivity on cigarette cravings in an fMRI study. We found that the influence of 
impulsivity on cigarette cravings was mediated by fronto-cingulate mechanisms. Given 
the high prevalence of cigarette smoking in several psychiatric disorders that are charac-
terized by significant levels of impulsivity, we conclude by identifying psychiatric patients 
as a target population whose tobacco-smoking habits deserve further behavioral and 
neuro-imaging investigation.
Keywords: cigarette, cravings, fMRi, individual differences, impulsivity
introduction
According to recent estimates, there are currently over a billion smokers worldwide and another 
300 million are foreseen for 2030 (1). The main issue with these numbers is that smoking harms 
nearly every organ in the body and is associated with significant disease and mortality (2). Among 
chronic cigarette smokers, it is estimated that about 50% will eventually be killed by tobacco-related 
diseases (3). Despite the growing recognition of the harmful health effects of cigarette, many smok-
ers persist in their use and have great difficulty quitting. Although over 70% of smokers want to 
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quit, only 5–17% of quit attempts are successful without proper 
support (4). For such reasons, tobacco is deemed as one of the 
most addictive drugs and significant research has been dedicated 
to the understanding of the psychobiological mechanisms 
underlying its addictive nature. As craving is a core feature of 
tobacco use disorder and a significant predictor of smoking 
relapse (5), several neuro-imaging studies have been performed 
to elucidate the neural mechanisms underlying smoking motiva-
tion. This literature has shown that the brain circuits involved 
in cigarette craving are not restricted to the classic brain reward 
system, but also encompass regions involved in self-referential 
processes and action planning, among others (6). Although 
we have gained valuable knowledge on the neurophysiology of 
cigarette  cravings, the implications of this literature is limited 
by the heterogeneity of results. One of the overlooked sources 
of heterogeneity is impulsivity, a personality trait playing a key 
role in addiction (7). Recently, our team has published a paper in 
Frontiers in Psychiatry (8), examining the influence of impulsiv-
ity on brain activations triggered by cigarette cues in chronic 
smokers. Putting this work into context is the aim of the current 
“focused review”.
Appetitive smoking cues
The clinical Relevance of cue Reactivity
For many smokers, the most worrying aspects of quitting are the 
relentless urges or desires to smoke a cigarette. Cravings tend to 
decrease in strength and frequency with longer abstinence period, 
yet a minority of ex-smokers still report strong urges 6 months 
after quitting (9). Empirical studies have shown that cravings – a 
core feature of tobacco use disorder in the DSM-V – are one of 
the most consistent predictors of relapse in ex-users (5), and 
accordingly their reduction is a primary objective of cessation 
treatment in smokers.
Craving is often defined as a subjective experience of want-
ing to use a drug, and thereby orienting oneself toward drug 
taking. Classical conditioning models stipulate that cravings are 
situation-specific and persistent, such that they can be triggered 
by stimuli previously associated with drug use, and reinstated 
years after abstinence (10). Tiffany and Conklin (11) have com-
plemented this model by arguing that craving is a multifaceted 
construct that involves various cognitive processes, including 
memory recollection of past drug taking and expectancy of 
subsequent use. According to them, drug-taking behaviors may 
occur in the absence of craving because they become automatized 
in the transition phase to dependence. The role of craving would 
therefore consist of cognitive processes that can fuel or prevent 
the execution of automatized drug use habits.
Craving may be divided into tonic (background) and phasic 
urges for a drug, both of which have been associated with smok-
ing relapse (5, 12, 13). They, respectively, reflect slowly changing 
states induced by abstinence, and a peak response with fast onset 
to appetitive drug cues. In experimental settings, exposure to 
appetitive smoking-related stimuli (e.g., videos, pictures, a lit 
cigarette) can trigger intense acute cravings (14) in abstinent 
smokers, even following a decline in tonic cravings. Likewise, a 
variety of laboratory stressors can elicit acute cravings in smok-
ers (15). These experimental paradigms offer a clear opportunity 
to improve our understanding of relapse mechanisms and the 
inability to quit smoking.
Neural correlates of smokers’ Response to 
Appetitive smoking cues
Over the last decade, considerable efforts have been spent on 
elucidating the neurobiological bases of cigarette cravings. Most 
studies used functional magnetic resonance imaging (fMRI) and 
presented pictures or videos (85% of studies) to depict smoking 
situations likely to provoke cravings. Relative to neutral material, 
appetitive smoking-related stimuli have been shown to consist-
ently elicit brain activations throughout cortical and sub-cortical 
regions in both abstinent and non-abstinent smokers (8, 16–25). 
A meta-analysis by Engelmann et al. (6) showed that during the 
viewing of appetitive cigarette-related cues, most significant 
clusters of activations were located within the extended visual 
cortex, followed by the anterior and posterior cingulate gyri, the 
medial and dorso-lateral prefrontal cortex, and the superior and 
middle temporal gyri. Smaller clusters were also observed in the 
insula and (dorsal) striatum. The widespread brain reactivity to 
drug cues validates the notion that craving is a multidimensional 
phenomenon implicating several cognitive processes. Contrary 
to the postulates of classic theories of drug addiction (10), these 
findings reveal that the brain craving response is not confined to 
the brain reward circuitry, and that other key brain regions need 
to be recruited in order to fully experience the complex craving 
response. The available results highlight a vastly distributed neu-
ronal network underlying smokers’ cravings, which stresses the 
importance of attentional/visual processing (extended visual sys-
tem) (16, 22, 24), self-referential processing [precuneus, posterior 
cingulate cortex (PCC)] (26–28), planning/regulatory processes 
[anterior cingulate cortex (ACC) and dorso-lateral prefrontal 
cortex (dlPFC)] (17, 29), emotional/interoceptive processes 
(insula) (18, 19, 29–31), and learning of automatic conducts 
(dorsal striatum) (28, 31, 32). Among these regions, frontal and 
limbic (insula) sub-regions seem to be the most directly related to 
the subjective experience of cigarette cravings (33).
In addition to the vast neuro-imaging literature examining 
brain responses of smokers to appetitive smoking-related mate-
rial, a few authors have investigated the specific neural correlates 
of appetitive drug-related processing by comparing it to the 
processing of appetitive stimuli other than drugs. As hypoth-
esized by Volkow et al. (34), drug addicts displayed a significant 
KeY coNcePT 1 | cigarette cravings
Cravings are defined as persistent urges, thoughts or desires to smoke a 
cigarette. Considered a core feature of tobacco use disorder in the recent 
DSM-V, cravings are one of the most consistent predictors of relapse in previ-
ous smokers.
KeY coNcePT 2 | impulsivity
Impulsivity is a predisposition toward rapid, unplanned reactions to internal 
or external stimuli without regard for the negative consequences of these 
reactions for the impulsive individuals and others.
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decrease in incentive salience toward natural compared to drug 
rewards, which helps explaining the heightened motivation for 
drug use observed in this population. Specifically in nicotine 
dependence, chronic cigarette smokers were found to be more 
reactive to cigarette cues relative to erotic pictures, whereas the 
opposite was observed in non-smokers. This difference in brain 
reactivity between smokers and non-smokers was found in the 
middle frontal gyrus (Brodmann area 6/8) (35), a region near 
the supplementary motor area thought to be involved in action 
planning and expectancy. This suggests a greater orientation, 
in smokers, toward the appetitive value of drugs than that of 
natural rewards. Finally, Versace et al. (36) found that smokers 
having decreased activity in the dorsal striatum while viewing 
erotic and romantic pictures compared to smoking cues were 
significantly more likely to have relapsed 6  months after quit-
ting. This suggests that smokers with decreased dorsal striatum 
activity to pleasant stimuli have greater difficulty quitting. It also 
suggests that reinforced drug habits promote a biased sensitivity 
toward the appetitive value of smoking compared to that of other 
rewards.
Our team has further explored the specificity of the neural corre-
lates of appetitive drug-related processing by contrasting the brain 
responses of smokers to appetitive and aversive smoking cues (37). 
The rationale of this study was based on evidence showing that 
smokers are roused by appetitive smoking stimuli, and that their 
consumption tends to be only mildly affected by anti-smoking 
stimuli depicting smoking’s negative value (38, 39). Using fMRI, 
30 chronic smokers viewed appetitive smoking-related, aversive 
smoking-related, and neutral images. Appetitive smoking-related 
images elicited increased activations in the medial prefrontal 
cortex (mPFC), the PCC and the precuneus, compared to aver-
sive smoking-related cues. This study demonstrated that smokers 
recruit brain regions involved in the processing of self-relevant 
material in response to appetitive smoking cues, compared to 
anti-smoking stimuli, highlighting a neurophysiologic bias toward 
the positive, rather than negative, value of smoking.
sources of Heterogeneity
When looking at individual studies assessing the neural correlates 
of cigarette craving, one finds that several factors contribute to 
the heterogeneity of findings between studies, such as abstinence 
levels, smoking expectancy, and craving suppression. There is 
also high individual variability within studies in the brain activa-
tions associated with exposure to smoking cues. It is therefore 
crucial to further understand this variability in brain reactivity 
to appetitive cigarette stimuli. Smoking dependence severity, 
sex-differences, motivation to quit, and genetic factors have 
been studied as potential factors of inter-individual variability in 
cigarette craving-induced brain responses. Comparatively, little 
attention has been paid to anxiety, depression, and personality 
traits. Table  1 summarizes the list of factors influencing brain 
reactivity to appetitive smoking cues.
Between-study Heterogeneity
Of all the variables that may influence the neural correlates of 
cue-elicited cigarette cravings, abstinence has been the most 
studied. On theoretical grounds, Wilson and Sayette (40) 
proposed that moderate and uncontrollable cravings may trig-
ger substantially different brain responses. Consistently with 
this idea, the meta-analysis from Engelmann et  al. (6) found 
that studies performed in deprived smokers (who report more 
intense cravings) had increased activations in the right superior 
frontal and the left lingual gyrus, relative to studies performed in 
non-deprived smokers. However, this meta-analysis also showed 
sizeable overlap between both sets of studies, which produced 
activations in 44 widespread clusters (6). Recently, Wilson and 
Sayette (40) updated the meta-analysis of Engelmann et al. (6). 
TABLe 1 | Factors influencing brain reactivity to appetitive smoking cues.
variable observations Relevant reference
Between-study factors
Abstinence During abstinence, cue-elicited cravings are more intense, and elicit stronger activations in the rostral 
anterior cingulate gyrus
(40)
Expectancy Smokers display greater rostral prefrontal cortex activations when they are told that they will be allowed 
to smoke a cigarette immediately after the scan
(22, 27, 32, 41)
Self-regulation of cravings Smokers display increased recruitment of frontal and cingulate regions when they are actively seeking 
to resist cigarette cravings
(16, 26, 42, 43)
within-study factors
Smoking dependence severity Smoking dependence severity is positively associated with increased brain reactivity to appetitive 
smoking cues. The brain regions underlying this increased brain reactivity remain to be determined. 
Heterogeneity of results is a concern
(19, 23, 31, 44–46)
Sex-differences Preliminary results that need to be confirmed suggest that the brain reactivity to appetitive smoking 
cues in women smokers is increased during the follicular phases of the menstrual cycle
(21, 47)
Motivation to quit Preliminary evidence suggests that motivation influences the brain responses of smokers to appetitive 
smoking cues
(48, 49)
Genetic factors Preliminary studies have linked dopamine- and acetylcholine-related genetic polymorphisms to the 
brain reactivity of smokers to appetitive smoking cues
(18, 19, 30)
Impulsivity trait Impulsivity trait is associated with increased cue-elicited cigarette cravings. This relationship may be 
mediated by fronto-cingulate mechanisms
(8)
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By contrasting 24 functional imaging studies involving deprived 
and non-deprived smokers, this updated meta-analysis showed 
that deprived smokers elicit stronger activations of the rostral 
ACC than smokers allowed to smoke ad libitum before the scan-
ning session. Interestingly, the rostral ACC is thought to play a 
critical role in the neurobiology of addiction, given that it receives 
dopaminergic inputs from the ventral tegmental area (10) and is 
involved in self-referential processes (50).
Smoking expectancy has also been shown to influence brain 
reactivity to appetitive smoking cues in chronic smokers. Wilson 
et al. (22) found that the expectation of being allowed to smoke 
a cigarette immediately after the scanning session was associated 
with increased activations in the ventro-medial PFC, the precen-
tral gyrus, and the right middle temporal gyrus. The same research 
team subsequently confirmed the influence of smoking on rostral 
PFC activations, but only in smokers unmotivated to quit (32). 
Hayashi et al. (41) found that smoking expectancy is associated 
with increased activation in the dlPFC. Finally, McBride et al. (27) 
found an association between smoking expectancy and activa-
tions in several frontal regions (dlPFC, dACC, dmPFC, mOFC), 
the PCC, and the precuneus. Overall, these results suggest that 
smoking expectancy is associated with increased activations in 
regions involved in action planning and reward valuation.
Finally, the ability to resist cigarette cravings was studied in four 
fMRI studies. Brody et al. (16) found that the PCC was engaged 
when participants were actively trying to suppress their urges, but 
not when they craved without trying to resist. Hartwell et al. (26) 
found that the ability to resist cigarette cravings was associated 
with increased activations in the left ACC, the ventro-/mPFC 
and the dlPFC. Zhao et al. (42) found that the inhibition of cue-
induced cigarette cravings (via re-appraisal) was associated with 
increased activations of the right dorsal ACC. Finally, Kober et al. 
(43) showed that cognitive down-regulation of cigarette cravings 
was associated with increased activations in regions involved in 
cognitive control [e.g., the dlPFC, dmPFC, and ventro-lateral 
prefrontal cortex (vlPFC)]. It is therefore possible that smokers 
with poor self-control abilities experience greater difficulty in 
controlling their urges, and this is (partially) mediated by lower 
activation of fronto-cingulate regions. Such results highlight the 
importance of self-regulation abilities in the subjective experi-
ence of cigarette cravings.
within-study Heterogeneity
Attention has also been paid to the severity of smoking depend-
ence and how it may influence brain cue reactivity. Apart from 
Vollstadt-Klein et al.’s (23) study, which found that severe smok-
ing dependence was associated with decreased activations in the 
amygdala, hippocampus, putamen, and thalamus, most studies 
have shown that smoking dependence is positively associated with 
smoking cue-elicited brain activations. Thus far, severe smoking 
dependence has been associated with increased activations in 
craving-related frontal and temporal regions (44, 45), the insula 
(19, 44), and the (superior) parietal cortex (31, 45, 46). As such, 
these results suggest that cigarette cues provoke a stronger brain 
craving response in smokers whose dependence is more severe.
In view of the clinical evidence showing that women and girls 
take less time to become dependent after initial use and have 
more difficulties quitting the habit (51, 52), preliminary studies 
examined the influence of sex-differences on the neural correlates 
of cigarette cravings. One of the factors contributing to these dif-
ferences may be that women crave cigarettes more than men and 
that their desire to smoke is influenced by hormonal fluctuations 
across the menstrual cycle. Therefore, we performed a study 
involving tobacco-smoking men (n = 15) and women (n = 19) 
who underwent an fMRI session, during which neutral and 
smoking-related images, known to elicit craving, were presented 
(47). Women were tested twice; once during early follicular and 
once during mid-luteal phase of their menstrual cycle. The analy-
sis did not reveal any significant sex differences in the cerebral 
activations associated with craving. This result contrasts with the 
fMRI findings from McClernon et al. (21), who found that women 
smokers exhibited larger cue reactivity in the right putamen, 
bilateral cuneus, and left middle temporal gyrus, while men had 
greater responses in the left hippocampus and left orbitofrontal 
cortex. Nevertheless, our study showed that brain activations in 
women varied across their menstrual cycle. More precisely, we 
found that female smokers had increased activations in the right 
angular/middle temporal gyrus in the follicular phase compared 
to the luteal phase. This latter result echoed the clinical reports 
of fluctuations in tobacco intake, withdrawal symptoms, and 
relapse rates across the menstrual cycle in women smokers (53, 
54), as well as the preclinical findings showing that higher levels 
of estrogen (follicular phase) are associated with more reinforcing 
effects of addictive drugs, whereas higher levels of progesterone 
(luteal phase) are associated with less reinforcing effects (55).
Some authors have shown that one’s intention to quit can 
impact prefrontal and limbic activity toward cigarette pictures 
(48) Furthermore, it was shown that smokers who are dissatis-
fied with their smoking behavior, relative to those more accepting 
of their tobacco use, were more reactive (e.g., orbitofrontal and 
limbic activations) to appetitive cigarette cues (49).
Finally, genetic factors have also been shown to modulate brain 
reactivity to smoking cues. An association has been found between 
the dopamine transporter gene SLC6A3 polymorphism and 
ventral striatal and medial orbitofrontal activations in response 
to smoking cues (18), a finding that was subsequently replicated 
in another independent sample (19). In addition, an association 
has been observed between the nicotinic receptor alpha-5 subunit 
gene (rs16969968) polymorphism and smoking cue-elicited acti-
vations in the hippocampus and dorsal striatum (30).
impulsivity
Personality traits, such as impulsivity, have been largely over-
looked as potential factors contributing to heterogeneity in 
KeY coNcePT 3 | Brain cue reactivity
Relative to neutral stimuli, appetitive smoking-related cues have been shown 
to elicit significant activations within the extended visual cortex, the (medial 
and dorsolateral) prefrontal cortex, the (anterior and posterior) cingulate, 
the temporal cortex, the insula, and the dorsal striatum. The widespread 
brain reactivity to cigarette cues suggests that craving is a multidimensional 
construct.
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the fMRI studies on cigarette cravings. Impulsivity constitutes 
a key diagnostic criterion for several mental disorders, most 
importantly for antisocial personality disorder, borderline 
personality disorder, impulse-control disorders, and attention 
deficit and hyperactivity disorder (ADHD) (56, 57). Yet, the 
definition and dimensions of impulsivity remain a source of 
debate. The most widely accepted definition of impulsivity is a 
predisposition toward rapid, unplanned reactions to internal or 
external stimuli without regard for the negative consequences 
of these reactions for the impulsive individuals and others (58). 
There are (at least) five dimensions of impulsivity, namely: (i) 
the difficulty in maintaining one’s attention toward stimuli; (ii) 
the initiation of actions without forethought or planification; 
(iii) sensation/novelty seeking; (iv) the indifference toward the 
long-term consequences of one’s choices and actions; and (v) the 
preference of immediate over larger delayed rewards, regardless 
of its disadvantages (59–63). Several scales have been developed 
to measure the different components of impulsivity (60, 63, 64). 
Research using these scales has shown that impulsivity has the 
characteristics of a personality trait: it is relatively stable in time 
and genetically transmitted (65, 66).
Impulsivity has been extensively studied using cognitive 
tasks. Bari and Robbins (67) have recently proposed a model that 
defines two dimensions of impulsivity largely studied in cognitive 
science: (1) a rapid action form, which refers to behaviors that are 
performed without consideration for their consequences and (2) 
a slower form involving the adoption of desired behaviors despite 
their negative consequences [Note: other researchers have pro-
posed similar models (68–70)]. Whereas the rapid form involves 
cognitive control processes allowing the flexible adaptation of 
behaviors to meet current demands (71, 72), the slower form 
entails value-based decision-making processes, which enable the 
selection of a behavior based on predicted positive or negative 
outcomes (73). While the rapid action form of impulsivity is 
assessed using response inhibition paradigms, such as the Go/
No-Go task, which require the suppression of a pre-potent motor 
response (71, 74, 75), the slower form of impulsivity is assessed 
using risky decision-making tasks that include rewards, such as 
the Iowa Gambling task (76, 77). Other components of impulsiv-
ity, such as the ability to delay rewards (78–82), have been studied 
in cognitive science, but to a lesser extent. Moreover, delay-
discounting tasks have been used less frequently than response 
inhibition and decision-making tasks in the functional imaging 
studies performed on the neural bases of impulsivity.
The Neurobiology of impulsivity
Response inhibition and risky decision-making tasks have been 
largely employed to examine the neural bases of impulsivity, using 
functional imaging. Although there may be a partial overlap 
between the neural mechanisms underlying cognitive control 
and risky decision-making, the available evidence suggests that 
response inhibition tasks recruit a fronto-lateral executive network 
(74, 75, 83–85), while risky decision-making tasks recruit reward-
related structures (86–88). Response inhibition tasks require 
withholding an already selected or initiated motor response. A 
recent meta-analysis of 30 fMRI studies (89) has shown that the 
vlPFC, the dlPFC, and the (dorsal) ACC are critically involved in 
response inhibition, presumably exerting executive control over 
the motor response. On the other hand, risky decision-making 
relies on mental processes that are mostly driven by reward 
seeking. A large-scale meta-analysis of 206 fMRI studies (90) has 
shown that rewards activate a valuation system composed of the 
ventro-medial PFC, the ventral ACC, and the (ventral) striatum. 
This is consistent with recent fMRI studies, highlighting the 
crucial role of these regions in risky decision-making (77, 91, 92). 
Thus, mounting evidence suggests that cognitive control involves 
fronto-lateral mechanisms (83), while risky decision-making 
relies on reward-related structures (70, 93).
impulsivity and cigarette smoking
Impulsivity plays a critical role in the etiology of substance use 
disorders (94). In adolescents, impulsivity has repeatedly been 
shown to predict the onset of substance use and subsequent esca-
lation of use (95, 96). In the case of tobacco, longitudinal studies 
have shown that impulsivity/hyperactivity traits at 12 years old 
predicted cigarette smoking 2 years later (97). In adolescents, it 
has also been shown that the preference for immediate rewards 
over larger delayed rewards promoted smoking acquisition (96). 
Likewise, an epidemiological study from Norway showed that 
impulsivity, as measured with the Barratt Impulsiveness Scale 
(BIS), was significantly associated with cigarette smoking initia-
tion, even after controlling for education level (98).
Increased impulsivity levels have repeatedly been highlighted 
in chronic cigarette smokers, relative to non-smokers, using 
various clinical and cognitive instruments. Using the BIS, several 
studies have reported high levels of impulsivity traits in chronic 
cigarette smokers, relative to non-smokers (78, 81, 99–101). 
In addition, it has been shown, using the Go–No-go task, that 
compared to healthy volunteers, cigarette smokers fail more 
frequently to inhibit pre-potent motor responses (82, 99). Finally, 
it has been repeatedly demonstrated that cigarette smokers are 
less likely than non-smokers to choose large delayed rewards over 
small immediate ones in delay-discounting tasks (78–82). On 
neurobiological grounds, preliminary fMRI studies have shown 
that chronic smoking is associated with decreased ventral striatal 
activations during reward-related tasks (102, 103), and abnormal 
lateral prefrontal activations during the Stroop task (104).
In abstinent smokers, impulsivity has been shown to be a 
significant predictor of smoking relapse. In both adolescent and 
adult smokers receiving treatment for smoking cessation, smok-
ers with impulsivity traits were found to be less likely to remain 
abstinent compared to non-impulsive smokers (105–107). 
Importantly, smokers who remained abstinent and those who 
relapsed did not differ at baseline in terms of number of smoked 
cigarettes, motivation to quit, confidence in their own abilities 
to quit, age, and sex. Similarly, Doran et al. (108) have shown, 
among smokers who relapsed during a 1-month intervention 
for smoking cessation, an association between impulsivity and 
shorter time to relapse. In order to explain the nature of the asso-
ciation between impulsivity and relapse, VanderVeen et al. (109, 
110) hypothesized that during abstinence, the rewarding value of 
tobacco may be increased in impulsive smokers; that is, impulsive 
smokers may crave more for cigarettes during abstinence than 
non-impulsive ones.
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impulsivity and cigarette cravings
A growing number of studies have evidenced an association 
between impulsivity trait and cravings for alcohol (111–113), 
cocaine (114, 115), methamphetamine (115), and tobacco 
(116–118). Although the link between impulsivity and craving is 
increasingly substantiated by evidence, the mechanisms underly-
ing this association remain poorly understood. Surprisingly, the 
neural mechanisms mediating the influence of impulsivity on 
cigarette cravings had not been studied (to our knowledge) until 
our research team sought to do so.
impulsivity and the Neural correlates of 
cigarette cravings
Impulsivity plays a pivotal role in the substance use onset, substance 
use relapse, and craving for psycho-active substances, including 
tobacco. Recently, our team performed an fMRI study seeking to 
examine the influence of trait impulsivity on the neural correlates 
of cue-elicited cigarette cravings (8). Thirty to 40 min prior to the 
scanning session, participants smoked a cigarette. While in the 
scanner, 31 chronic smokers viewed appetitive smoking-related 
and neutral images and reported their subjective craving levels. 
They also completed the BIS. The processing of appetitive smok-
ing cues elicited, in smokers, activations in midline brain regions 
(the mPFC, ACC, and PCC) that have been repeatedly found to 
be activated in fMRI studies on tobacco cravings (6), and to be 
involved in self-referential processing (119–121). In addition, 
we observed a significant positive relationship between the total 
BIS score and subjective craving levels (r =  0.624; p <  0.001). 
Among second-order factors of the BIS (attentional, motor, 
and non-planning), it was the non-planning subscale that was 
the most significantly correlated with craving ratings (r = 0.625; 
p < 0.001). A negative correlation (r = −0.449; p = 0.015) was also 
observed between the total BIS score and activations in the PCC. 
Among second-order factors, only the non-planning subscale 
was significantly correlated with PCC activations (r = −0.440; 
p = 0.017). Such results were consistent with previous findings 
showing that the PCC is involved in resisting cigarette cravings 
(16). Based on the observed associations between impulsivity and 
PCC activations, we conducted functional connectivity analyses 
with the psycho-physiological interaction (PPI) method, using the 
PCC as the seed region. PPI analyses revealed significant negative 
coupling between the PCC and the dorsal ACC, the right dlPFC, 
and a region in the vicinity of the left insula. Thus, lower activa-
tions of the PCC, found in impulsive smokers, were associated 
with higher activations of brain regions involved in emotional 
(insula) and attentional (dACC and dlPFC) responses to smoking 
cues. Our findings highlighted the need for further investiga-
tions on the role of the PCC in drug addiction, as it is one of the 
most consistently activated regions in fMRI studies examining 
the neural correlates of cue-induced alcohol, drug, and tobacco 
cravings (6, 122, 123). Besides its role in self-referential process-
ing, the PCC may be involved in the ability to resist cravings for 
psycho-active substances, including tobacco. Theoretically, an 
impaired functioning of the PCC may (indirectly) result in a lack 
of self-control over substance (tobacco) cravings. Although the 
PCC is not assumed to be a core cognitive control region, a neuro-
imaging meta-analysis of 24 fMRI studies using stop-signal tasks 
recently showed that the PCC is one of the main activated regions 
during response inhibition (124).
Contrary to our expectations, we did not observe any direct 
relationship between impulsivity and dysfunctional activations 
in the dlPFC or the vlPFC (though the dlPFC emerged as sig-
nificantly coupled with the PCC). Critically involved in cognitive 
control (74, 75, 89), these frontal regions have been shown to 
be implicated in efforts to inhibit cigarette cravings (26, 43). 
Although the reasons for these negative findings remain elusive, it 
is possible that the impulsivity trait refers to more complex neural 
processes than those involved in decision-making and cognitive 
control. Highly impulsive individuals are stimulus-bound and 
focus on immediate rather than long-term events. They also tend 
to lack introspection and have impaired mentalization abilities 
(125). Such characteristics are very unlikely to be captured by 
risky decision-making or response inhibition tasks. Over and 
above the dlPFC and vlPFC, the PCC is critical for self-relevant 
processes, such as mindfulness, mentalizing, and self-reflection 
(119–121). Altogether, these results should encourage researchers 
who will pursue future studies on the neurobiology of impulsivity 
in the addiction field to pay attention to components of impulsiv-
ity other than cognitive control and risky decision-making.
Future Perspectives: Tobacco smoking in 
Psychiatric disorders
Several psychiatric disorders are characterized by high or moder-
ate levels of impulsivity, namely ADHD, bipolar, cluster-B per-
sonality, psychotic, and substance use disorders (7, 58, 126–129). 
Moreover, the prevalence of cigarette smoking is increased in 
patients with psychiatric disorders. In the US, approximately 29% 
of the population has a psychiatric disorder, and these individuals 
consume approximately 41% of the production of tobacco in the 
country (130). Although the prevalence of tobacco smoking has 
declined in the general population during the last decades, the 
consumption of tobacco products remained strikingly elevated in 
patients with schizophrenia, bipolar disorder, major depressive 
disorder, post-traumatic stress disorder (PTSD), and ADHD, 
with prevalence estimates of 60–74, 66, 57, 40–86, and 40–42%, 
respectively (130–136). Elevated rates of tobacco smoking have 
also been observed in individuals with substance use disorders 
(137). It has been shown, indeed, that more than a third of patients 
with an alcohol use disorder and more than half of individuals who 
misuse (abuse/dependence) illicit drugs are also nicotine depend-
ent (138). Therefore, psychiatric patients represent populations of 
interest for the study of the relationship between impulsivity and 
tobacco cravings, at both the behavioral and neural level.
explanatory Models
Two major hypotheses have been advanced to account for the 
elevated prevalence of tobacco smoking in psychiatric patients. 
The self-medication hypothesis proposes that psychiatric patients 
smoke cigarettes to relieve their psychiatric symptoms (anxiety, 
depression) or cognitive deficits (139). In support of this hypoth-
esis, numerous studies have shown that the acute administra-
tion of nicotine (the main psycho-active agent of tobacco) to 
schizophrenia patients improves some of their cognitive deficits 
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(e.g., attention, speed of processing, and working memory), and 
their impaired ability to filter out irrelevant information (140–
142). Preliminary studies have shown that nicotine administra-
tion (or tobacco smoking) also improves cognitive performance 
in patients with ADHD (143, 144), bipolar disorder (145), and 
depression (20, 145).
Despite these findings, the self-medication hypothesis has 
been criticized over the years for its implied justification of 
tobacco smoking in psychiatric patients. Alternatively, the 
addiction vulnerability hypothesis proposes that neurobiological 
dysfunctions of the brain reward system, common to psychiatric 
and substance use disorders, make psychiatric patients more 
vulnerable to the rewarding effects of various psycho-active 
substances, including tobacco (139, 146, 147). In support of the 
addiction vulnerability hypothesis, several studies have shown 
that tobacco is more reinforcing for schizophrenia patients than 
it is for non-psychiatric smokers. Schizophrenia patients are 
more prone to smoke high-tar cigarettes, and they tend to smoke 
more cigarettes per day, extract more nicotine per cigarette, and 
have higher serum nicotine and cotinine (nicotine metabolite) 
levels compared to control smokers (148, 149). Preliminary 
evidence also suggests that cravings for cigarette are increased in 
schizophrenia patients (150, 151), 15 min or 72 h after smoking 
their last cigarette. Preliminary studies have shown that cigarette 
cravings are also elevated in other psychiatric disorders, including 
ADHD and PTSD (152–155). Despite these evidences, the neural 
correlates of tobacco cravings have been scarcely examined in 
psychiatric patients or individuals with psychiatric vulnerabili-
ties (156–158).
Future studies will need to replicate and extend the findings 
demonstrating that cigarette cravings are increased in psychiat-
ric patients, and to clarify whether bottom-up (e.g., motivational 
salience) or top-down (e.g., self-regulation) neural mechanisms 
explain these findings. To explore this self-regulation hypoth-
esis, impulsivity will need to be measured in these populations. 
Although most studies in the comorbidity field have not focused 
on tobacco smoking specifically, mounting evidence shows that 
impulsivity is a key mediator of the association between sub-
stance use and psychiatric disorders, including ADHD, bipolar 
disorder, cluster-B personality disorders, and schizophrenia 
(7, 126–128). Several fMRI studies have examined the neural 
correlates of impulsivity in psychiatric patients (mostly bipolar 
disorder and schizophrenia) having no comorbid substance use 
disorders. Using various response inhibition tasks, these stud-
ies have shown that psychiatric patients have abnormal brain 
activations in regions involved in cognitive control, such as the 
dlPFC, the vlPFC, and/or the cingulate gyrus (159–163). Despite 
the variability in results, such findings pave the way to future 
neuro-imaging studies on drug (cigarette) cravings in psychi-
atric patients examining the interactions between cognitive 
control brain regions and those involved in craving experience.
conclusion
Given that craving is a core feature of tobacco use disorder and 
a significant predictor of smoking relapse, several fMRI studies 
have examined the neural correlates of (cue-induced) cigarette 
urges. The available literature has demonstrated that cigarette 
cravings elicit activations in regions involved in self-referential 
processing, planning/regulatory processes, emotional respond-
ing, attentional biases, and automatic conducts. Unfortunately, 
the implications of this literature are limited by the heterogeneity 
of results. Sources of heterogeneity include both methodological 
(abstinence, smoking expectancies, self-regulation) and indi-
vidual factors (severity of smoking dependence, sex-differences, 
motivation to quit, genetic factors). Surprisingly, the potential 
influence of impulsivity has been largely ignored, although 
impulsivity is positively associated with cigarette cravings and 
smoking relapse. The influence of impulsivity on cigarette crav-
ings is possibly mediated by fronto-cingulate mechanisms, as 
recently demonstrated by our team. Future behavioral and neuro-
imaging studies will need to pay attention to the high prevalence 
of cigarette smoking in several psychiatric disorders, as these 
disorders are characterized by significant impulsivity.
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